πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 206 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 11975056

AADC polynucleotides for the treatment of Parkinson's disease

VOYAGER THERAPEUTICS, INC. Β· Granted Tue May 07 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 02 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11938125

Use of Hsp70 as a regulator of enzymatic activity

ZEVRA DENMARK A/S Β· Granted Tue Mar 26 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11885817

Biomarkers and methods for detection of seizures and epilepsy

Cognizance Biomarkers, LLC Β· Granted Tue Jan 30 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11851711

DNA methylation biomarkers for cancer diagnosing

Arizona Board of Regents on Behalf of the University of Arizona Β· Granted Tue Dec 26 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 21 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11813123

Ultrasound responsive micro-composite markers

The Regents of the University of California Β· Granted Tue Nov 14 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11814440

Glypican 2 as a cancer marker and therapeutic target

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Nov 14 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11815516

Protein biomarkers for diseases associated with the contact activation system

Takeda Pharmaceutical Company Limited Β· Granted Tue Nov 14 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11806385

Biomarkers for monitoring immune transformation

BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA Β· Granted Tue Nov 07 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11793825

Biomarkers for predicting responsiveness to decitabine therapy

THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted Tue Oct 24 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 19 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11788141

MVD as epigenetic marker for the identification of immune cells, in particular CD56+ NK ce

Precision for Medicine GmbH Β· Granted Tue Oct 17 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 12 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11787764

Heptamethine cyanines for use as fluorescent markers of the biliary and renal systems

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Oct 17 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 12 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11759506

AADC polynucleotides for the treatment of Parkinson's disease

VOYAGER THERAPEUTICS, INC. Β· Granted Tue Sep 19 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 14 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11717553

Combined plant extract for getting rid of mites and acne and preparation method and use th

Nanjing Institute for Comprehensive Utilization of Wild Plants, All China Federation of Supply and Marketing Corporation Β· Granted Tue Aug 08 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 03 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11714089

Combination of markers for diagnosing cancer

The Medical Research, Infrastructure and Health Services Fund of the Tel-Aviv Medical Center Β· Granted Tue Aug 01 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 27 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11692030

Biomarkers and methods for detection of seizures and epilepsy

Cognizance Biomarkers, LLC Β· Granted Tue Jul 04 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 29 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11598782

Biomarkers and methods for detection of seizures and epilepsy

Cognizance Biomarkers, LLC Β· Granted Tue Mar 07 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11578371

Biomarkers for predicting tumor response to and toxicity of immunotherapy

MIRA DX, INC. Β· Granted Tue Feb 14 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11567073

Receptor tyrosine kinase biomarkers

United Kingdom Research and Innovation Β· Granted Tue Jan 31 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 26 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11549113

Human alzheimer's disease and traumatic brain injury associated tau variants as biomarkers

ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY Β· Granted Tue Jan 10 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 05 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11542560

Microbiome markers and therapies for autism spectrum disorders

Board of Regents on Behalf of Arizona State University Β· Granted Tue Jan 03 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 29 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11478511

Lymphocyte biomarkers for determining the clinical response to cell therapy

Takeda Pharmaceutical Company Limited Β· Granted Tue Oct 25 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 20 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11445997

Ultrasound imaging of biomarker sensitive hydrogels

SENTIOMED, INC. Β· Granted Tue Sep 20 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 15 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11447500

Thienopyridine derivatives and pharmaceutical composition comprising same

Wellmarker Bio Co., LTD. Β· Granted Tue Sep 20 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 15 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11433102

Compositions and methods for treating Parkinson's disease (PD) and related disorders

Finch Therapeutics Holdings LLC Β· Granted Tue Sep 06 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 01 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted